Our Expertise



We work closely with our clients to craft personalized development strategies, investor presentations, business plans, financials, and market analysis reports to help you pass through the investor screening and due diligence process.
We work alongside investors and global companies to assess medical device, healthcare IT, diagnostic, and drug development opportunities and craft win-win partnerships for both sides. See Investor Services to learn more.
Business Plans

From bench side to doctor's side, to bringing your idea to the market, every company needs a detailed development and business plan. 


For medtech companies, before defining the business strategy, the market, the go-to-market plans, and the financial model, a company must demonstrate deep understanding of its technology, and present honest assessments of clinical validation, reimbursement, regulatory hurdles to support its growth plan.


Blue Stream Partners guides clients through assessing these important steps and presenting them in an investor friendly format demonstrating a well-defined feasible business plan.

Investor Presentations

In an increasingly fast world, you only get a quick chance to wow your investors. A concise and well-designed presentation is a key tool in effectively demonstrating your management's talent, an important market need, and a novel technological solution.


Our clients can attest to the importance our presentations played in facilitating investor interest which led to successful investments


Through our fund raising guidance, we assist clients to identify and connect with suitable strategic partners and investors and accompany you throughout the due diligence and negotiations to close the deal.



Strategic Partnerships

In the ever global medtech sector, partnering with market leaders provides an important source of early credibility, market knowledge, and value building. Partners often share in development costs, and can be a source of early funding as well.

Market Research

The medical market can be segmented in many different ways. Many products can be targeted to different users in different clinical settings, such as hospital, clinics, and home use.


Through market research and competitive analysis directly with thought leaders in your field we help you map your competition, identify your strengths and weaknesses, allowing you to better define and focus on your competitive advantage.


Aim to uncover opportunities and threats in various possible target markets and relevant clinical setting to ensure you approach the target market best suited to your product.

Funding for medtech companies, is a multi-stage process requiring important value building milestones every step of the way.

Interim Managment

Experience successfully guiding companies through the difficult early stages can be the difference between success and failure. In select cases, our partners come "inside" the companies to develop the strategy, manage the development process, and meet milestones necessary to raise additional funds and bring on talented long-term management.

Strategy Refinement

On your way to building a solid business plan, one has to ask important questions to define goals and objectives with key strategic analyses necessary to making strong decisions.


In Med tech, this process includes additional elements, unique to the Life Sciences field, necessitating background knowledge and experience; reimbursement, regulatory, clinical, and evolving market knowledge. Through our strategic consulting process, we will ensure all these are clearly addressed and integrated into your strategy, our goal being to enable you to concentrate your limited resources on the greatest opportunities, increase sales and achieve a sustainable competitive advantage.

Financial Modeling

Once a development strategy is in place, building a concrete and in-depth budget shows management depth and experience. For medtech companies, this means getting supplier and consultant quotes and mapping out realistic timelines for management overhead.


A strong market penetration strategy is ultimately conveyed to investors  through conservate financial forecasts which demonstrate significant value potential. Both a top-down market view and an in-depth bottom-up view of sales should demonstrate the potential upside of successful development.